Patents by Inventor Philip F. Stahel

Philip F. Stahel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
    Patent number: 8911733
    Abstract: Disclosed is the use of agents and compositions that selectively inhibit the alternative complement pathway for the inhibiting or treating physiological damage resulting from traumatic brain injury (TBI), spinal cord injury (SCI), or related conditions. Preferred reagents for use in inhibition of damage resulting from TBI or SCI include those that inhibit factor B, with anti-factor B antibodies representing a particularly preferred agent.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: December 16, 2014
    Assignees: MUSC Foundation for Research Development, The Regents of the University of Colorado, a body corporate
    Inventors: Vernon Michael Holers, Joshua M. Thurman, Stephen Tomlinson, Philip F. Stahel